Report: Clinical Risk Map: 2015

Report: Clinical Risk Map 2015


Aon's latest Clinical Trials Risk Map highlights insurance regulations and complexities for more than 80 countries throughout the world and provides insights from Aon's global network and clinical trials expertise.

2015 Key Highlights

  • Identifies country-specific clinical trials liability insurance requirements that trial sponsors must comply with in order to commence a clinical trial
    • In most countries, local admitted certificates of insurance with specific requirements are usually required for regulatory filings prior to trial approval
    • Delays or errors in certificates of insurance can result in delays in regulatory filings and approvals by ethics committees, ministries of health and other oversight regulatory authorities, which can negatively impact the reputation of life sciences companies and their clinical trial timelines
  • Features eight symbols that illustrate clinical trials insurance characteristics, with two new symbols that highlight new characteristics for clinical trial sponsors. These symbols distinguish between:
    • Countries where clinical trials insurance policies cover both pre-screened subjects in addition to the standard coverage of enrolled subjects; and
    • Countries where direct insurance reimbursement to the subject is allowed versus the standard reimbursement to the study sponsor

Life Sciences Clinical Trials Risk Map Highlights
Life Sciences Clinical Trials Risk Map
Aon Global Clinical Trials Capabilities Overview

For additional information contact James Walters, Aon Risk Solutions Life Sciences Practice Leader